Funded Health Care Startups in Baltimore
Across the 16 most recent Baltimore-area health care funding rounds shown here, AbsoluteCARE’s $105M (2021-01-07) stands out as the only disclosed round fa…
Across the 16 most recent Baltimore-area health care funding rounds shown here, AbsoluteCARE’s $105M (2021-01-07) stands out as the only disclosed round far above the rest; the next-largest disclosed amounts cluster around $2M (e.g., Pantheon Vision at $2M on 2024-04-02, Dracen Pharmaceuticals at $2M on 2023-08-10, and Emocha Health at $2M on 2022-10-24). Multiple smaller rounds concentrate in the $500K–$2M band, including Kubanda Cryotherapy’s $500K (2025-09-09), Astek Diagnostics’ $500K (2025-06-17), and CurieDx’s $300K (2023-06-01).
The list is also temporally concentrated: the most recent entry is Kubanda Cryotherapy on 2025-09-09, while the oldest shown is Spine Align dated 2020-09-14, spanning about five years. Stage labeling is mixed—four entries explicitly show “Seed” (Kubanda Cryotherapy, Astek Diagnostics, Pantheon Vision, Forte), while five rows show “undisclosed” amounts (Gallion Health 2025-07-08; Volo Kids Foundation 2023-08-08; BetterU 2023-06-15; Relavo 2023-02-15; Gallion Health and others), and multiple companies fall under “Series Unknown” or “Venture - Series Unknown” classifications.
Most recent rounds
16 shownRelated listings
Frequently asked
What’s the largest disclosed health care round in this Baltimore list, and how does it compare to the rest of the disclosed amounts?
AbsoluteCARE’s $105M on 2021-01-07 is the clear outlier; after that, the largest disclosed amounts are much lower and often sit around $2M (e.g., Pantheon Vision at $2M on 2024-04-02 and Dracen Pharmaceuticals at $2M on 2023-08-10), with several sub-$1M disclosures like Kubanda Cryotherapy and Astek Diagnostics at $500K.
Do the rounds cluster in time near the most recent entries, or are they evenly spread across 2020–2025?
They’re weighted toward the recent window: 2025 contains three rows (Kubanda Cryotherapy on 2025-09-09; Gallion Health on 2025-07-08; Astek Diagnostics on 2025-06-17). The table also reaches back to 2020-09-14 (Spine Align), so it spans roughly five years, but the latest year shows the densest activity in the displayed set.
How much of the data is missing disclosed amounts, and does that affect any largest/size conclusions?
Five of the 16 rows have “undisclosed” amounts (Gallion Health on 2025-07-08; Volo Kids Foundation on 2023-08-08; BetterU on 2023-06-15; Relavo on 2023-02-15, plus the other undisclosed rows shown). Because the only clearly dominant disclosed figure is AbsoluteCARE’s $105M (2021-01-07), comparisons among disclosed sizes remain anchored to that outlier and the $500K–$2M band visible elsewhere.
Which stages appear most often in this Baltimore health care set, and what does that imply about stage mix?
“Seed” is explicitly shown in four rows (Kubanda Cryotherapy on 2025-09-09; Astek Diagnostics on 2025-06-17; Pantheon Vision on 2024-04-02; Forte on 2023-12-19). The remaining visible classifications are split across “Series Unknown” and “Venture - Series Unknown” (e.g., Intelehealth 2023-12-20; Emocha Health 2022-10-24; AbsoluteCARE 2021-01-07), indicating that disclosed stage visibility is limited for many rounds.
Are there notable outliers on the low end within disclosed amounts?
Within disclosed amounts, the smallest figure shown is $10K, appearing in Complete Wellness on 2023-08-23 and DioTeX on 2022-05-10. Those $10K rounds sit far below the common mid-range disclosures like CurieDx at $300K (2023-06-01) and the $500K entries (Kubanda Cryotherapy 2025-09-09; Astek Diagnostics 2025-06-17).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.